Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal...
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBI
Target Price
The average target price of COLO-B.CO is 678 and suggests 24% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in
Buy
Sell